HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 4 filers reported holding HAEMONETICS CORP in Q2 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $2,000 | -90.0% | 40 | -92.7% | 0.00% | -100.0% |
Q4 2014 | $20,000 | +5.3% | 545 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $19,000 | 0.0% | 545 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $19,000 | +5.6% | 545 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $18,000 | -98.8% | 545 | -98.6% | 0.00% | -96.8% |
Q2 2013 | $1,557,000 | +21.4% | 37,664 | +19.9% | 0.03% | +24.0% |
Q1 2013 | $1,283,000 | -21.7% | 31,424 | -21.7% | 0.02% | -26.5% |
Q4 2012 | $1,639,000 | +15.1% | 40,127 | +126.0% | 0.03% | +3.0% |
Q3 2012 | $1,424,000 | +118.1% | 17,755 | +101.6% | 0.03% | +94.1% |
Q2 2012 | $653,000 | +17.2% | 8,805 | +10.2% | 0.02% | +21.4% |
Q1 2012 | $557,000 | +19.8% | 7,990 | +5.2% | 0.01% | +16.7% |
Q4 2011 | $465,000 | +22.4% | 7,595 | +16.8% | 0.01% | +9.1% |
Q3 2011 | $380,000 | -4.5% | 6,505 | +5.1% | 0.01% | +10.0% |
Q2 2011 | $398,000 | +23.2% | 6,190 | +25.7% | 0.01% | +25.0% |
Q1 2011 | $323,000 | +80.4% | 4,925 | +74.0% | 0.01% | +60.0% |
Q4 2010 | $179,000 | – | 2,830 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |